BAREM DE ACTIVITI EFECTUATE N PRACTICA DE SPECIALITATE

DE STUDENII ANULUI IV FARMACIE, 2012-2013

1.

Se va urmri depozitarea i conservarea medicamentelor cu termen de valabilitate,

substanelor inflamabile, etc.
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
2.Participarea sub ndrumarea farmacistului la prepararea medicamentelor magistrale i
elaborri. Comentati forma farmaceutica, descrierea materiilor prime, preparare,
conditionare, control, actiune si intrebuintari.
Rp./ Talci
Zinci oxydi
Glyceroli
Aquae destillatae

aa 25 g.
sau

Mixtura mentolata

M.f. suspensio
D.s. extern
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
1

....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
Rp./
Nystatini
Benzocaini
Natrii tetraboratis
Glyceroli

0,2 g.
0,2 g.
2 g.
q.s.ad. 20 g.

sau

Glicerina boraxata

M.f. suspensio
D.s. extern
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
Rp/

Metronidazoli
Nystatini
Chloramphenicoli
Cacao olei

0,25 g
0,075 g
0,10 g
q.s.

M.f. globuli
D.t.d. nr. X
D.s. extern, intravaginal, 1 ovul seara
sau Cervugid sau alt preparat sub forma de supozitoare vaginale tip suspensie
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................

.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
Rp/

Acidi salicylici
Acidi benzoici
Vaselini

2g
4g
24 g

sau Dermovate unguent

M.f. ung.
D.s. extern
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................

Solutio aethacridini lactas 0.1% (sau alt preparat tip soultie coloidala existent in
farmacie)
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................

.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
Solutio methylthionini chloridum 1% (sau alta solutie de coloranti)
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
3.Descrierea unor preparate injectabile si a unor produse oftalmice.
Solutio iniectabile acidi ascorbici
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................

Solutio iniectabile phytomenadioni

.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
Visine
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
Tobradex sau alt colir tip suspensie cu antibiotic existent in farmacie
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
4.Forme farmaceutice cu tincturi si extracte (5 exemple din produsele existente in farmacie)
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
5

.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
5.Documentarea n farmacie: cri i reviste de specialitate.
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
.......................................................................................................................................................
..........................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................
....................................................................................................................................................

Data

Farmacist diriginte